BHP invests £300k in innovative service improvement projects
Birmingham Health Partners (BHP), the second city’s University-NHS partnership, has announced the inaugural recipients of its Seed Fund programme, awarding more than £300,000 to four projects acros…
Review of 25 years reveals AI healthtech is beginning to listen to patients
Patients experiences of their health conditions are slowly being integrated into AI studies, a review of 25 years of healthcare publications has found.
Published in the Lancet Digital Health, th…
Leukaemia trial tests Covid vaccine strategies to combat immune suppression
Patients with the most common form of leukaemia – Chronic Lymphocytic Leukaemia (CLL) – are being invited to take part in a trial that could help them build Covid-19 antibodies following vaccinatio…
Funding renewal allows experimental cancer therapy research to continue in Birmingham
New and innovative ways to detect and treat cancer being trialled at the University of Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.
The Birmingham Experimental…
New device provides early diagnosis for cardiac tamponade
A new diagnostic device, developed to monitor against post-surgery heart strangulation risk, has been introduced by a company formed by Birmingham cardiothoracic surgeon Hazem Fallouh.
Patients …
New heart attack drug trialled in Birmingham
A new partnership between BHP clinical-academic institutions and Acticor Biotech will see patients with heart attacks treated with glenzocimab, a promising new class of drug, for the first time.
T…